Ablation, Research and Risk Factors - Cardiovascular Update

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Biosense Webster's zero fluoroscopy workflow is the first and only such workflow available in a radiofrequency (RF) cardiac ablation device.

Ablation

Ablation Atrial Fibrillation AFIB Heart Rhythm

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Journal of the American Heart Association

JANUARY 9, 2024

Herein, we provide an overview of the current knowledge on the pathophysiology and risk factors for AF in adult congenital heart disease, with a special focus on the existing challenges in AF ablation. Emerging imaging modalities and ablation techniques might have a role to play.

Congenital Heart Disease

Congenital Heart Disease Atrial Fibrillation Congenital Heart Disease

Analysis of risk factors for complications in echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation

Journal of Cardiothoracic Surgery

JULY 15, 2024

The feasibility of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM) has been previously reported. However, limited invest.

Ablation

Ablation Risk Factors Cardiomyopathy Research

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

NCDR at Heart Rhythm 2024: Pediatric Subcutaneous ICD; Catheter Ablation For Atrial Tachyarrhythmias; More

American College of Cardiology

MAY 20, 2024

Several abstracts at Heart Rhythm 2024, held May 16-19 in Boston, MA, featured data from the NCDR suite of registries.

Heart Rhythm

Heart Rhythm Pediatrics Ablation Atrial Fibrillation

Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association

Hypertension Journal

AUGUST 5, 2024

Hypertension is a leading risk factor for cardiovascular morbidity and mortality. Individual patient responses vary, and further research is needed to identify those who may benefit most. Hypertension, Ahead of Print. In fact, only 23% of individuals with high blood pressure in the United States achieve treatment goals.

Hypertension

Hypertension Blood Pressure Pharmacology Risk Factors

Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillation

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

BackgroundObesity is an important risk factor for atrial fibrillation (AF) development and progression. Furthermore, obesity reduces health-related quality of life (HRQoL), an essential indicator for treatment efficacy of AF ablation. Heart rhythm was systematically monitored during follow-up.

Quality of Life

Quality of Life Obesity Atrial Fibrillation Ablation

Study Shows Medtronic ICM Accurately Predicts Risk Thresholds for AFib Patients Using AI

DAIC

JANUARY 29, 2025

Using the data, researchers built an algorithm capable of predicting patients risk of needing AF-related healthcare in the next 30-day period, in addition to predicting clinically meaningful reductions in patient-reported quality of life. By 2030, approximately 12.2 million people in the U.S. Piccini, M.D., 2024, May 15).

AFIB

AFIB Atrial Fibrillation Quality of Life Heart Rhythm

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation

NOVEMBER 29, 2023

In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.

Atrial Fibrillation

Atrial Fibrillation Risk Factors Ablation Arrhythmia

Model for predicting the recurrence of atrial fibrillation after monopolar or bipolar radiofrequency ablation in patients with AF and mitral valve disease

Journal of Cardiothoracic Surgery

MAY 15, 2024

This study aimed to identify the risk factors for postoperative atrial fibrillation in patients with valvular atrial fibrillation, and establish predictive models of atrial fibrillation recurrence.

Atrial Fibrillation

Atrial Fibrillation Bicuspid/Mitral Risk Factors Ablation

National AFib Awareness Month: A Call to Action for Physicians Worldwide

ADN Center of Excellence

SEPTEMBER 2, 2024

From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. Key Considerations for AFib Management Effective management of AFib requires a comprehensive approach that includes accurate diagnosis, risk stratification, and individualized treatment plans.

AFIB

AFIB Atrial Fibrillation Innovation Heart Rhythm

National AFib Awareness Month: A Call to Action for Physicians Worldwide

ADN Center of Excellence

SEPTEMBER 2, 2024

From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. Key Considerations for AFib Management Effective management of AFib requires a comprehensive approach that includes accurate diagnosis, risk stratification, and individualized treatment plans.

AFIB

AFIB Atrial Fibrillation Innovation Heart Rhythm

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

Late-breaking Clinical Trial Results from FARADISE, adMIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm

Heart Rhythm Atrial Fibrillation Ablation Quality of Life

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation

DAIC

DECEMBER 14, 2023

Launching the first FDA -approved PFA technology is not just a milestone; the PulseSelect PFA system is setting a new standard in safety for AF ablation with excellent efficacy and efficiency 1. In my clinical experience with the catheter, it was designed for AF ablation procedures.

Atrial Fibrillation

Atrial Fibrillation Ablation Technology Heart Failure

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

MARCH 28, 2024

The VARIPULSE Platform is comprised of the VARIPULSE Catheter, a fully integrated variable-loop multielectrode catheter; the TRUPULSE Generator, a pulsed field ablation (PFA) generator; and the CARTO 3 System VARIPULSE Software, which provides full integration with the world's leading 3D cardiac mapping system.

Atrial Fibrillation

Atrial Fibrillation AFIB Ablation Pulmonary

AF and Dementia

Dr. Sanjay Gupta

JANUARY 17, 2022

The whole process can easily take 10-15 years and therefore patients may continue to be managed in sub-optimal manner for this duration of time even when there is available research to say that things could be done better. Today I wanted to talk about some troubling research in the field of AF. What about ablation?

Dementia

Dementia Ablation Atrial Fibrillation Risk Factors

Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE?CS study

European Journal of Heart Failure

NOVEMBER 3, 2023

Cox proportional hazard analysis showed that iCS was significantly associated with the primary outcome in the unadjusted model; however, the association disappeared after adjustment for log-transformed B-type natriuretic peptide level, LVEF, a history of ventricular tachycardia/fibrillation, and ablation for ventricular tachycardia after diagnosis.

Atrial Fibrillation

Atrial Fibrillation Heart Failure Tachycardia Arrhythmia

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Comparison of prognosis and analysis of related risk factors among three different left atrial appendage occlusion procedures in patients with atrial fibrillation

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

Multivariable logistic regression was employed to identify risk factors for incomplete occlusion and PDL.ResultsPeri-procedural complication rates were low among all groups, with 2.9% Persistent AF and SCr were significant risk factors for incomplete occlusion and PDL. in the RFCA combined with the LAAO group.

Risk Factors

Risk Factors Atrial Fibrillation Ablation Thrombosis

The association between features of epicardial adipose tissue and the risks of early recurrence after catheter ablation in patients with atrial fibrillation

Frontiers in Cardiovascular Medicine

FEBRUARY 18, 2025

However, there is limited research on the contribution of EAT to the risk of AF recurrence (AFR). Logistic regression was used to identify independent risk factors and to build a model to predict recurrence. The clinical, atrial, and EAT characteristics of patients with and without AFR were compared.

Atrial Fibrillation

Atrial Fibrillation Ablation Risk Factors Research

The relationship between the 3D electroanatomical mapping parameters of the left atrial posterior wall and the recurrence of paroxysmal atrial fibrillation

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2025

BackgroundPulmonary vein isolation (PVI) remains the cornerstone of catheter ablation in paroxysmal atrial fibrillation (PAF). ConclusionsThis study demonstrates that both PWSA and PVLVA were independent risk factors for AF recurrence. However, the recurrence of AF after PVI needs further investigation.

Atrial Fibrillation

Atrial Fibrillation Risk Factors Pulmonary Ablation

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Analysis of risk factors for complications in echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation

Webinars

NCDR at Heart Rhythm 2024: Pediatric Subcutaneous ICD; Catheter Ablation For Atrial Tachyarrhythmias; More

Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association

Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillation

Study Shows Medtronic ICM Accurately Predicts Risk Thresholds for AFib Patients Using AI

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Model for predicting the recurrence of atrial fibrillation after monopolar or bipolar radiofrequency ablation in patients with AF and mitral valve disease

National AFib Awareness Month: A Call to Action for Physicians Worldwide

National AFib Awareness Month: A Call to Action for Physicians Worldwide

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

Late-breaking Clinical Trial Results from FARADISE, adMIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

AF and Dementia

Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE?CS study

Published Research

Published Research

Comparison of prognosis and analysis of related risk factors among three different left atrial appendage occlusion procedures in patients with atrial fibrillation

The association between features of epicardial adipose tissue and the risks of early recurrence after catheter ablation in patients with atrial fibrillation

The relationship between the 3D electroanatomical mapping parameters of the left atrial posterior wall and the recurrence of paroxysmal atrial fibrillation

Stay Connected